Search

Author/Creator An, In Bok

1. A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome. Issue 6 (18th December 2021)

Authors:
Kim, Eun Ran; Park, Jeong Su; Kim, Jin Hee; Oh, Ji Young; Oh, In Jeong; Choi, Da Hyun; Lee, Yu seol; Park, I. Seul; Kim, SeungWon; Lee, Da Hyun; Cheon, Jae Hee; Bae, Jin‐Woo; Lee, Minyoung; Cho, Jin Won; An, In Bok; Nam, Eun Joo; Yang, Sang‐In; Lee, Myung‐Shik; Bae, Soo Han; Lee, Yong‐ho
Journal:
Hepatology
Issue:
Volume 75:Issue 6(2022)
Page Start:
1523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A glycosylated Fc‐fused glucagon‐like peptide‐1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutide. Issue 8 (3rd June 2020)

Authors:
An, In Bok; Byun, Mi Sun; Yang, Sang In; Choi, Yuri; Woo, Jung Won; Jang, Hak Chul; Sung, Young Chul
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 8(2020)
Page Start:
1455
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search